FT Openova — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
Conversio Health provides personalized therapeutics, technologies, and services for patients with chronic respiratory conditions and their caregivers.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesSan Luis Obispo, US
Taylor Cline(Chief Executive Officer)inScott Waddell(Chief Technology Officer)inDylan Herr(Executive Officer)inChristopher Wooley(Executive Officer)Amanda Bringe(Chief Operating Officer)inChristopher Dooley(Chief Growth Officer)in
Board seatRachel Kern· per SEC Form D · $25M raise · filed Oct 2025
Cincinnati, US
Gary Winzenread(Executive Officer, Director)
BoardKim Sell(Director)Jonathan Phillips(Director)Doug Groh(Director)MICHAEL VENERABLE(Director)
Board seatRachel Kern· per SEC Form D · $4M raise · filed Apr 2025
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.